These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8710426

  • 1. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
    Małecka-Tendera E, Koehler B, Muchacka M, Wazowski R, Trzciakowska A.
    Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
    Enzi G, Crepaldi G, Inelmen EM, Bruni R, Baggio B.
    Clin Neuropharmacol; 1988 May; 11 Suppl 1():S173-8. PubMed ID: 3052815
    [Abstract] [Full Text] [Related]

  • 3. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G, Haidinger G, Francesconi M, Langmayr N, Prager R, Schoberberger R, Toplak H, von Kalckreuth G, Kunze M.
    Acta Med Austriaca; 1995 May; 22(5):95-101; 104-9. PubMed ID: 8651045
    [Abstract] [Full Text] [Related]

  • 4. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N, Craddock D, Lavielle R, Keen H.
    Diabete Metab; 1987 May; 13(6):598-602. PubMed ID: 3329122
    [Abstract] [Full Text] [Related]

  • 5. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M, Pisculli M, Petraroli AR, Riganelli S, Saracino A, Siani V.
    Clin Ter; 1990 Jun 15; 133(5):289-97. PubMed ID: 2143712
    [Abstract] [Full Text] [Related]

  • 6. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT, Richman RM, Steinbeck KS, Caterson ID.
    Int J Obes Relat Metab Disord; 1995 Mar 15; 19(3):181-9. PubMed ID: 7780494
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of dexfenfluramine in a weight loss program for obese infertile women.
    Galletly C, Clark A, Tomlinson L.
    Int J Eat Disord; 1996 Mar 15; 19(2):209-12. PubMed ID: 8932560
    [Abstract] [Full Text] [Related]

  • 8. [A multicenter open study of dexfenfluramine in Italy. The efficacy and safety of using dexfenfluramine in treating patients with simple or complicated obesity. The DIMOS Group].
    Enzi G.
    Ter Arkh; 1997 Mar 15; 69(5):71-5. PubMed ID: 9235665
    [Abstract] [Full Text] [Related]

  • 9. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
    Ditschuneit HH, Flechtner-Mors M, Dolderer M, Fulda U, Ditschuneit H.
    Horm Metab Res; 1993 Nov 15; 25(11):573-8. PubMed ID: 8288160
    [Abstract] [Full Text] [Related]

  • 10. [Different therapies in the treatment of obesity in hypertensive patients].
    Monego ET, Peixoto Mdo R, Jardim PC, Sousa AL, Braga VL, Moura MF.
    Arq Bras Cardiol; 1996 Jun 15; 66(6):343-7. PubMed ID: 9035450
    [Abstract] [Full Text] [Related]

  • 11. Dexfenfluramine reduces cardiovascular risk factors.
    Bremer JM, Scott RS, Lintott CJ.
    Int J Obes Relat Metab Disord; 1994 Apr 15; 18(4):199-205. PubMed ID: 8044193
    [Abstract] [Full Text] [Related]

  • 12. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML, Zelissen PM, Koppeschaar HP, Nieuwenhuyzen Kruseman AC, Lutterman JA, van der Veen EA.
    Int J Obes Relat Metab Disord; 1995 May 15; 19(5):299-304. PubMed ID: 7647820
    [Abstract] [Full Text] [Related]

  • 13. Effect of 6 months therapy with dexfenfluramine in obese patients: studies in the United Kingdom.
    Finer N, Craddock D, Lavielle R, Keen H.
    Clin Neuropharmacol; 1988 May 15; 11 Suppl 1():S179-86. PubMed ID: 3052816
    [Abstract] [Full Text] [Related]

  • 14. [Drug therapy of obesity--results of treatment with dexfenfluramine].
    Ivković-Lazar T, Stokić E, Lepsanović L.
    Med Pregl; 1990 May 15; 43(5-6):232-5. PubMed ID: 2287309
    [Abstract] [Full Text] [Related]

  • 15. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
    Héraïef E.
    Rev Med Suisse Romande; 1997 Jan 15; 117(1):19-24. PubMed ID: 9082531
    [Abstract] [Full Text] [Related]

  • 16. Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine.
    Finer N, Finer S, Naoumova RP.
    Int J Obes; 1989 Jan 15; 13 Suppl 2():91-3. PubMed ID: 2613434
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy and acceptability of dexfenfluramine in women consulting in gynecology. 336 overweight patients treated for 3 months].
    Elia D, Auclair J, Rey C.
    Rev Fr Gynecol Obstet; 1992 Jun 15; 87(6):361-9. PubMed ID: 1631479
    [Abstract] [Full Text] [Related]

  • 18. Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial.
    Andersen T, Astrup A, Quaade F.
    Int J Obes Relat Metab Disord; 1992 Jan 15; 16(1):35-40. PubMed ID: 1314242
    [Abstract] [Full Text] [Related]

  • 19. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
    Lafreniere F, Lambert J, Rasio E, Serri O.
    Int J Obes Relat Metab Disord; 1993 Jan 15; 17(1):25-30. PubMed ID: 8383638
    [Abstract] [Full Text] [Related]

  • 20. Place of dexfenfluramine in the management of obesity.
    Guy-Grand BJ.
    Clin Neuropharmacol; 1988 Jan 15; 11 Suppl 1():S216-23. PubMed ID: 3052820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.